Lantern Pharma Inc.
LTRN
$3.16
-$0.03-0.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.87% | -14.40% | -15.66% | -13.28% | -7.13% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -47.11% | 1.64% | 2.26% | 48.71% | -37.57% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -20.00% | 148.01% | -- |
| Total Current Assets | -17.52% | -15.62% | -15.22% | -10.59% | -8.93% |
|
|
|||||
| Total Current Assets | -17.52% | -15.62% | -15.22% | -10.59% | -8.93% |
| Net Property, Plant & Equipment | -17.81% | -14.36% | 27.46% | 10.86% | -15.30% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 14.69% | 23.55% | 0.00% |
| Total Assets | -17.50% | -15.59% | -14.88% | -10.44% | -8.97% |
|
|
|||||
| Total Accounts Payable | 21.14% | -5.23% | 5.29% | 50.14% | 71.13% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -15.36% | -3.29% | 20.30% | -7.87% | 2.89% |
| Total Finance Division Other Current Liabilities | -30.49% | 101.75% | -57.59% | -6.80% | 38.39% |
| Total Other Current Liabilities | -30.49% | 101.75% | -57.59% | -6.80% | 38.39% |
| Total Current Liabilities | -1.03% | 20.27% | -21.73% | 16.38% | 47.61% |
|
|
|||||
| Total Current Liabilities | -1.03% | 20.27% | -21.73% | 16.38% | 47.61% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -36.74% | -43.83% | 71.85% | 250.64% | -74.63% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -1.46% | 18.65% | -20.63% | 17.30% | 44.87% |
|
|
|||||
| Common Stock & APIC | 0.15% | 0.30% | 0.20% | 0.14% | 0.20% |
| Retained Earnings | -5.97% | -8.38% | -6.86% | -8.17% | -9.85% |
| Treasury Stock & Other | -14.48% | 708.70% | -283.33% | -447.37% | 101.77% |
| Total Common Equity | -20.82% | -20.34% | -14.01% | -13.52% | -12.57% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -20.82% | -20.34% | -14.01% | -13.52% | -12.57% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -20.82% | -20.34% | -14.01% | -13.52% | -12.57% |
|
|
|||||